|
DDX46 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.27960000040339E-07 |
| Normal-vs-Stage3 |
2.1094237467878E-15 |
| Normal-vs-Stage4 |
7.81175124586753E-12 |
| Stage1-vs-Stage2 |
4.255400E-01 |
| Stage1-vs-Stage3 |
2.374200E-01 |
| Stage1-vs-Stage4 |
3.142200E-01 |
| Stage2-vs-Stage3 |
1.382410E-01 |
| Stage2-vs-Stage4 |
1.694400E-01 |
| Stage3-vs-Stage4 |
9.216200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.22329999999671E-05 |
| Normal-vs-Asian |
6.18630036086643E-10 |
| Caucasian-vs-AfricanAmerican |
1.484590E-01 |
| Caucasian-vs-Asian |
9.742400E-01 |
| AfricanAmerican-vs-Asian |
2.090600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
2.335800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(41-60Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(61-80Yrs) |
1.75737202567916E-12 |
| Normal-vs-Age(81-100Yrs) |
5.037100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.367000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.735400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.037000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.035600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.690600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.879800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.037500E-02 |
| Classical-VS-Follicular |
1.596200E-01 |
| Classical-VS-Other |
1.052200E-01 |
| Classical-VS-Normal |
1.00380037615366E-10 |
| Tall-VS-Follicular |
2.294200E-01 |
| Tall-VS-Other |
6.497400E-01 |
| Tall-VS-Normal |
9.31499322120999E-12 |
| Follicular-VS-Other |
3.579800E-01 |
| Follicular-VS-Normal |
7.66064989221604E-12 |
| Other-VS-Normal |
6.19170000000224E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
2.50129916778974E-11 |
| N0-vs-N1 |
5.718200E-01 |
|
|
